Su Yin Lim

6PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersTumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Jesse R Brown, Bernadette Pedersen, Georgina V Long

|May 14, 2025
Blood-based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy.

Brie-Anne Mannah, John J Park, Su Yin Lim

|Apr 22, 2022
Protein-based classification of melanoma differentiation subtypes.

Su Yin Lim, Bernadette Pedersen, Helen Rizos

|Jun 02, 2021
Melanoma Cell State-Specific Responses to TNFα.

Su Yin Lim, Sara Alavi, Zizhen Ming

|Jul 04, 2018
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms.

Su Yin Lim, Helen Rizos

|Mar 10, 2016
Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis.

David Jiang, Su Yin Lim

Pageof 1

Frequent Collaborators

3 joint publications

Helen Rizos

1 joint publications

Bernadette Pedersen

1 joint publications

Georgina V Long

1 joint publications

Nigel G Maher